Your Ad Here
PatientsVille.com> Nipent Report List> Nipent Side Effects
View, Compare, Rank and Report Nipent Side Effects. Browse Nipent FDA Adverse Reports and participate in Nipent discussion, find alternative treatments and find ways to avoid or reduce side effects associated with using Nipent. Post a question to Nipent community or Ask a Doctor. Browse More Drugs and their Side Effects: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
Enter Your Nipent Side Effect:
This is a Quick Way to report your Nipent Side Effect
View All Nipent Side Effects Ranked by Patients
Post a Detailed Nipent Report
Reporting Your Nipent side effect will help others recognize and deal with Nipent side effects.
Ask Nipent Community
Ask patient community about Nipent related health issues.
Nipent FDA Reports
Nipent adverse events reported to FDA.

Have You Experienced Nipent Side Effects? PatientsVille.com collects and analyzes side effects reported by Nipent users, such as .

Nipent Side Effects Summary

Nipent FDA adverse reports: 95. View All Nipent FDA Adverse Reports

Nipent FDA safety alerts: No

Reported deaths: 27

Reported hospitalizations: 74

Nipent Dosage, Warnings, Usage.

Add Nipent Side Effect:

Nipent Side Effects

Most Reported Nipent Side Effects

Recent Nipent Side Effect Reports

More Nipent Side Effect Reports

Questions about Nipent Side Effects

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes


Share Your Nipent Experience, Join the Discussion:

Search For a Nipent Side Effect, Symptom or Condition

Loading
Nipent Adverse Effect Reports (FDA)
Quick-Add Your Side Effect:

< Previous Nipent Side Effects Page  Showing 81-120 of 95 Next Nipent Side Effects Page>

Nipent Side Effects Report: 4994279-5,Multiple Myeloma
on Mar 13, 2003 Female patient from FRANCE , 59 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: multiple myeloma (What is multiple myeloma?). Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous. Patient was hospitalized.

Nipent Side Effects Report: 4994277-1,Adult T-cell Lymphoma/leukaemia
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: adult t-cell lymphoma/leukaemia on Mar 14, 2003 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: (4 Mg/m2, 1 X Per 2 Wk), Intravenous.

Nipent Side Effects Report: 4994272-2,Diffuse Large B-cell Lymphoma
Adverse event was reported on Mar 13, 2003 by a Female patient taking Nipent (Nipent Label) (Dosage: 4 Mg/m^2 (1 X Per 2 Wk)) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 67 years of age, After Nipent was administered, patient had the following side effects: diffuse large b-cell lymphoma. Patient was hospitalized.

Nipent Side Effects Report: 4994270-9,Diffuse Large B-cell Lymphoma
on Mar 13, 2003 Female patient from FRANCE , 50 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: diffuse large b-cell lymphoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk). Patient was hospitalized.


Nipent Side Effects Report: 4994268-0,Mantle Cell Lymphoma
on Mar 14, 2003 Female patient from FRANCE , 74 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: mantle cell lymphoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous. Patient was hospitalized.

Nipent Side Effects Report: 4994266-7,Breast Cancer
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: breast cancer (What is breast cancer?) on Mar 14, 2003 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: 4 Mg/m^2 (4 Mg/m2, 1 X Per 2 Wk), Intravenous.

Nipent Side Effects Report: 4994206-0,Oesophageal Carcinoma
Adverse event was reported on Mar 14, 2003 by a Female patient taking Nipent (Nipent Label) (Dosage: 4 Mg/m2, 1x Per 2 Wk, Intravenous) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 70 years of age, After Nipent was administered, patient had the following side effects: oesophageal carcinoma.

Nipent Side Effects Report: 4994204-7,Prostate Cancer
on Mar 13, 2003 Male patient from FRANCE , 67 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: prostate cancer (What is prostate cancer?). Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus. Patient was hospitalized.

Nipent Side Effects Report: 4994202-3,Prostate Cancer
on Mar 13, 2003 Male patient from FRANCE , 68 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: prostate cancer (What is prostate cancer?). Nipent dosage: 4 Mg/m2/day (every Two Weeks). Patient was hospitalized.

Nipent Side Effects Report: 4994197-2,Prostate Cancer
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: prostate cancer (What is prostate cancer?) on Mar 13, 2003 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: 4 Mg/m2/day (every 2 Weeks). Patient was hospitalized.

Nipent Side Effects Report: 4994193-5,Colon Cancer, Metastasis
Adverse event was reported on Mar 13, 2003 by a Female patient taking Nipent (Nipent Label) (Dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 63 years of age, After Nipent was administered, patient had the following side effects: colon cancer, metastasis. Patient was hospitalized.

Nipent Side Effects Report: 4994150-9,Lung Neoplasm Malignant, Squamous Cell Carcinoma
on Mar 14, 2003 Female patient from FRANCE , 59 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: lung neoplasm malignant, squamous cell carcinoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous.

Nipent Side Effects Report: 4994146-7,Basal Cell Carcinoma
on Mar 13, 2003 Female patient from FRANCE , 73 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: basal cell carcinoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus. Patient was hospitalized.

Nipent Side Effects Report: 4994138-8,Basal Cell Carcinoma
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: basal cell carcinoma on Mar 13, 2003 from FRANCE Additional patient health information: Female patient , 77 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk),. Patient was hospitalized.

Nipent Side Effects Report: 4994134-0,Basal Cell Carcinoma
Adverse event was reported on Mar 13, 2003 by a Female patient taking Nipent (Nipent Label) (Dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 73 years of age, After Nipent was administered, patient had the following side effects: basal cell carcinoma. Patient was hospitalized.

Nipent Side Effects Report: 4994128-5,Skin Cancer
on Mar 13, 2003 Female patient from FRANCE , 75 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: skin cancer (What is skin cancer?). Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus. Patient was hospitalized.

Nipent Side Effects Report: 4977093-6,Disease Recurrence, Pericarditis
on Mar 29, 2006 Male patient from UNITED STATES , 49 years of age, weighting 150.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: disease recurrence, pericarditis. Nipent dosage: 0.1905 Mg/m2 (4 Mg/m2, Q 3 Wk), Intravenousq. During the same period patient was treated with CYCLOPHOSPHAMIDE (28.5714 Mg/m2 (600 Mg/m2, Q 3 Wk), Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), RITUXIMAB (RITUXIMAB) (RITUXIMAB) (17.84571 Mg/m2 (375 Mg/m2, Q 3 Wk), Intravenous) (View Rituximab (rituximab) (rituximab) Side Effects and Rituximab (rituximab) (rituximab) Label ), ACYCLOVIR (ACICLOVIR) (ACICLOVIR) (View Acyclovir (aciclovir) (aciclovir) Side Effects and Acyclovir (aciclovir) (aciclovir) Label ), BACTRIM DS (SULFAMETHOXAZOLE, TRIMETHOPRIM (SULFFAMETHOXAZOLE, TRIMETH (View Bactrim Ds (sulfamethoxazole, Trimethoprim (sulffamethoxazole, Trimeth Side Effects and Bactrim Ds (sulfamethoxazole, Trimethoprim (sulffamethoxazole, Trimeth Label ). Patient was hospitalized.

Nipent Side Effects Report: 4977092-4,Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Hyperbilirubinaemia, Hyperkalaemia, Hyperphosphataemia, Hyponatraemia, Metabolic Acidosis, Renal Failure
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hyperbilirubinaemia, hyperkalaemia, hyperphosphataemia, hyponatraemia, metabolic acidosis, renal failure on Mar 31, 2006 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with t-cell prolymphocytic leukaemia and. Nipent dosage: 1.5486 Mg (10.84 Mg, Once Weekly), Intravenous. During the same period patient was treated with CAMPATH (12.8571 Mg (30 Mg, Three Times Weekl)) (View Campath Side Effects and Campath Label ), LACRI TUBE (OINTEMENT) (View Lacri Tube (ointement) Side Effects and Lacri Tube (ointement) Label ), VALCYTE (VALGANCICLOVIR HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE) (View Valcyte (valganciclovir Hydrochloride (valganciclovir Hydrochloride) Side Effects and Valcyte (valganciclovir Hydrochloride (valganciclovir Hydrochloride) Label ), VORICONAZOLE (VORICONAZOLE) (VORICONAZOLE) (View Voriconazole (voriconazole) (voriconazole) Side Effects and Voriconazole (voriconazole) (voriconazole) Label ), BACTRIM (View Bactrim Side Effects and Bactrim Label ), FLOVENT (FLUTICASONE PROPIONATE) (FLUTICASONE PROPIONATE) (View Flovent (fluticasone Propionate) (fluticasone Propionate) Side Effects and Flovent (fluticasone Propionate) (fluticasone Propionate) Label ), TOBRADEX (DEXAMETHASONE, TOBRAMYCIN) (DEXAMETHASONE, TOBRAMYCIN) (View Tobradex (dexamethasone, Tobramycin) (dexamethasone, Tobramycin) Side Effects and Tobradex (dexamethasone, Tobramycin) (dexamethasone, Tobramycin) Label ). Patient was hospitalized.

Nipent Side Effects Report: 4950184-1,Anxiety, Asthenia, Dementia Alzheimer's Type, Depression, Muscle Spasms
Adverse event was reported on Mar 10, 2006 by a Female patient taking Nipent (Nipent Label) (Dosage: 0.6667 Mg (20 Mg, Once Monthly), Intravenous) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 48 years of age, After Nipent was administered, patient had the following side effects: anxiety (What is anxiety?), asthenia, dementia alzheimer's type, depression (What is depression?), muscle spasms.

Nipent Side Effects Report: 4949394-9,Anaemia, Enteritis, Herpes Zoster, Leukopenia, Lymphadenopathy, Neutropenia, Upper Respiratory Tract Infection
on Mar 03, 2006 Female patient from PUERTO RICO , 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: anaemia, enteritis, herpes zoster, leukopenia, lymphadenopathy, neutropenia, upper respiratory tract infection. Nipent dosage: (1.25 Mg/m2, Day #2, 3, 4), Intravenous. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) ((375 Mg/m2, Day #1), Intravenous) (View Rituximab (rituximab) (rituximab) Side Effects and Rituximab (rituximab) (rituximab) Label ), GEMCITABINE (GEMCITABINE) (GEMCITABINE) ((750 Mg/m2, Day #2), Intravenous) (View Gemcitabine (gemcitabine) (gemcitabine) Side Effects and Gemcitabine (gemcitabine) (gemcitabine) Label ), NEULASTA ((6 Mg, Day #5), Subcutaneous) (View Neulasta Side Effects and Neulasta Label ). Patient was hospitalized.

Nipent Side Effects Report: 4928559-6,Acute Respiratory Distress Syndrome, Cardiomegaly, Hepatosplenomegaly, Lung Consolidation, Lung Neoplasm, Pulmonary Fibrosis, Renal Failure, Sepsis, Urinary Bladder Haemorrhage
on Feb 10, 2006 Male patient from UNITED STATES , 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: acute respiratory distress syndrome, cardiomegaly, hepatosplenomegaly, lung consolidation, lung neoplasm, pulmonary fibrosis (What is pulmonary fibrosis?), renal failure, sepsis (What is sepsis?), urinary bladder haemorrhage. Nipent dosage: 0.2143 Mg/m2 (4 Mg/m2, Day 1 On Weeks 1, 4, 7, 10, 13, And 16). During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) (53.5714 Mg/m2 (375 Mg/m2, Week 1 X 3 Days, Weeks 4-16 X 1 Day/week)) (View Rituximab (rituximab) (rituximab) Side Effects and Rituximab (rituximab) (rituximab) Label ), CYCLOPHOSPHAMIDE (32.1429 Mg/m2 (600 Mg/m2, Day 1 On Weeks 1, 4, 7, 10, 13, And 16)) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), PREDNISONE (PREDNISONE) (PREDNISONE) (View Prednisone (prednisone) (prednisone) Side Effects and Prednisone (prednisone) (prednisone) Label ). Patient was hospitalized.

Nipent Side Effects Report: 4919286-X,Anaemia, Aplasia Pure Red Cell
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: anaemia, aplasia pure red cell on Feb 08, 2006 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 0.1905 Mg/m2 (4 Mg/m2, Every 3 Wks), Intravenous. During the same period patient was treated with CYCLOPHOSPHAMIDE (28.5714 Mg/m2 (600 Mg/m2, Every 3 Wks), Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), RITUXIMAB (RITUXMAB) (RITUXIMAB) (17.8571 Mg/m2 (375 Mg/m2, Every 3 Wks), Intravenous) (View Rituximab (rituxmab) (rituximab) Side Effects and Rituximab (rituxmab) (rituximab) Label ), ACYCLOVIR (ACICLOVIR) (ACICLOVIR) (View Acyclovir (aciclovir) (aciclovir) Side Effects and Acyclovir (aciclovir) (aciclovir) Label ), BACTRIM (SULFAMETHOXAZOLE, TRIMETHOPRIM) (TABLETS) (SULFAMETHOXAZOLE, (View Bactrim (sulfamethoxazole, Trimethoprim) (tablets) (sulfamethoxazole, Side Effects and Bactrim (sulfamethoxazole, Trimethoprim) (tablets) (sulfamethoxazole, Label ). Patient was hospitalized.

Nipent Side Effects Report: 4919285-8,Palpitations, Pericarditis
Adverse event was reported on Feb 08, 2006 by a Male patient taking Nipent (Nipent Label) (Dosage: 0.1905 Mg/m2 (4 Mg/m2, Q 3 Wks), Intravenous) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 49 years of age, weighting 136.7 lb, After Nipent was administered, patient had the following side effects: palpitations, pericarditis. During the same period patient was treated with CYCLOPHOSPHAMIDE (28.5714 Mg/m2 (600 Mg/m2, Q 3 Wks), Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), RITUXIMAB (RITUXMAB) (RITUXIMAB) (17.8571 Mg/m2 (375 Mg/m2, Q 3 Wks), Intravenous) (View Rituximab (rituxmab) (rituximab) Side Effects and Rituximab (rituxmab) (rituximab) Label ), ACYCLOVIR (ACICLOVIR) (ACICLOVIR) (View Acyclovir (aciclovir) (aciclovir) Side Effects and Acyclovir (aciclovir) (aciclovir) Label ), BACTRIM (SULFAMETHAZOLE, TRIMETHOPRIM, (TABLETS) (SULFAMETHOXAZOLE, TR (View Bactrim (sulfamethazole, Trimethoprim, (tablets) (sulfamethoxazole, Tr Side Effects and Bactrim (sulfamethazole, Trimethoprim, (tablets) (sulfamethoxazole, Tr Label ). Patient was hospitalized.

Nipent Side Effects Report: 4910446-0,Acute Respiratory Distress Syndrome, Cardiomegaly, Hepatosplenomegaly, Lung Consolidation, Lung Neoplasm, Pulmonary Fibrosis, Renal Failure, Respiratory Failure, Sepsis Syndrome
on Jan 27, 2006 Male patient from UNITED STATES , 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: acute respiratory distress syndrome, cardiomegaly, hepatosplenomegaly, lung consolidation, lung neoplasm, pulmonary fibrosis (What is pulmonary fibrosis?), renal failure, respiratory failure, sepsis syndrome. Nipent dosage: 0.2143 Mg/m2 (4 Mg/m2, Day 1 On Weeks 1, 4, 7, 10, 13, And 16). During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) (53.5714 Mg/m2 (375 Mg/m2, Week 1 X 3 Days, Weeks 4-16 X 1 Day/week)) (View Rituximab (rituximab) (rituximab) Side Effects and Rituximab (rituximab) (rituximab) Label ), CYTOXAN (32.1429 Mg/m2 (600 Mg/m2, Day 1 On Weeks 1, 4, 7, 10, 13, And 16)) (View Cytoxan Side Effects and Cytoxan Label ). Patient was hospitalized.

Nipent Side Effects Report: 4906004-4,Hypocalcaemia, Hypokalaemia, Pyrexia, Urinary Tract Infection
on Jan 30, 2006 Male patient from UNITED STATES , 72 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: hypocalcaemia, hypokalaemia, pyrexia, urinary tract infection (What is urinary tract infection?). Nipent dosage: 0.381 Mg (8 Mg, Q 21 D), Intravenous. During the same period patient was treated with CYTOXAN (57.1429 Mg (1200 Mg, Q 21 D), Intravenous) (View Cytoxan Side Effects and Cytoxan Label ), RITUXAN (38.0952 Mg (800 Mg, Q 21 D), Intravenous) (View Rituxan Side Effects and Rituxan Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Side Effects and Atorvastatin Calcium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Side Effects and Hydrochlorothiazide Label ), ACIPHEX (RABEPRAZOLE SODIUM) (RABEPRAZOLE SODIUM) (View Aciphex (rabeprazole Sodium) (rabeprazole Sodium) Side Effects and Aciphex (rabeprazole Sodium) (rabeprazole Sodium) Label ), K DUR (POTASSIUM CHLORIDE) (POTASSIUM CHLORIDE) (View K-dur (potassium Chloride) (potassium Chloride) Side Effects and K-dur (potassium Chloride) (potassium Chloride) Label ), UROXATROL (View Uroxatrol Side Effects and Uroxatrol Label ), ASPIRIN (View Aspirin Side Effects and Aspirin Label ). Patient was hospitalized.

Nipent Side Effects Report: 4899669-7,Body Temperature Increased, Cardiac Failure Congestive, Hypotension, Multi-organ Failure, Oedema, Pneumonia, Pneumonitis, Respiratory Distress
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: body temperature increased, cardiac failure congestive, hypotension, multi-organ failure, oedema, pneumonia (What is pneumonia?), pneumonitis, respiratory distress on Jan 19, 2006 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 128.5 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 0.1905 Mg/m2 (4mg/m2, Every 21 Days); Intravenous. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) (17.8571 Mg/m2 (375 Mg/m2, Every 21 Days); Intravenous) (View Rituximab (rituximab) (rituximab) Side Effects and Rituximab (rituximab) (rituximab) Label ), CYTOXAN (28.5714 Mg/m2 (600 Mg/m2, Every 21 Days); Intravenous) (View Cytoxan Side Effects and Cytoxan Label ), NEULASTA (PEGFILGRASTIM) (PEGFILGRASTIM) (0.5714 Mg (6 Mg, 2 Every 21 Days); Subcutaneous) (View Neulasta (pegfilgrastim) (pegfilgrastim) Side Effects and Neulasta (pegfilgrastim) (pegfilgrastim) Label ), ACYCLOVIR (View Acyclovir Side Effects and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Side Effects and Azithromycin Label ), BACTRIM DS (SULFAMETHOXAZOLE, TRIMETHOPRIM) (SULFAMETHOXAZOLE, TRIMETH (View Bactrim Ds (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimeth Side Effects and Bactrim Ds (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimeth Label ), LASIX (View Lasix Side Effects and Lasix Label ), PREDNISONE (View Prednisone Side Effects and Prednisone Label ). Patient was hospitalized.

Nipent Side Effects Report: 4890577-4,Blood Potassium Decreased, Urinary Tract Infection
Adverse event was reported on Jan 13, 2006 by a Male patient taking Nipent (Nipent Label) (Dosage: 0.381 Mg (8 Mg, Q 21 D), Intravenous) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 72 years of age, After Nipent was administered, patient had the following side effects: blood potassium decreased, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CYTOXAN (57.1429 Mg (1200 Mg, Q21 D), Intravenous) (View Cytoxan Side Effects and Cytoxan Label ), RITUXAN (38.0952 Mg (800 Mg, Q 21 D)) (View Rituxan Side Effects and Rituxan Label ), NORVASTATIN (View Norvastatin Side Effects and Norvastatin Label ), HYDROCHLOATHIAZIDE (View Hydrochloathiazide Side Effects and Hydrochloathiazide Label ), ACIPHEX (RABEPRAZOLE SODIUM) (RABEPRAZOLE SODIUM) (View Aciphex (rabeprazole Sodium) (rabeprazole Sodium) Side Effects and Aciphex (rabeprazole Sodium) (rabeprazole Sodium) Label ), K DUR (POTASSIUM CHLORIDE) (POTASSIUM CHLORIDE) (View K-dur (potassium Chloride) (potassium Chloride) Side Effects and K-dur (potassium Chloride) (potassium Chloride) Label ), UROXATROL (View Uroxatrol Side Effects and Uroxatrol Label ), ASPIRIN (View Aspirin Side Effects and Aspirin Label ). Patient was hospitalized.

Nipent Side Effects Report: 4872150-7,Atrial Fibrillation, Cardiac Failure Congestive, Cardiomegaly, Pneumonia, Pulmonary Oedema
on Dec 21, 2005 Male patient from UNITED STATES , 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, cardiomegaly, pneumonia (What is pneumonia?), pulmonary oedema. Nipent dosage: 0.381 Mg (8 Mg, Q 21 Days), Intravenous. During the same period patient was treated with RITUXUAN (RITUXIMAB) (35.7143 Mg (750 Mg, Q 21 Days), Intravenous) (View Rituxuan (rituximab) Side Effects and Rituxuan (rituximab) Label ), CYTOXAN (57.1429mg (1200 Mg, Q 21 Days), Intravenous) (View Cytoxan Side Effects and Cytoxan Label ), CRESTOR (ROSUVASTATIN CALCIUM) (TABLETS) (View Crestor (rosuvastatin Calcium) (tablets) Side Effects and Crestor (rosuvastatin Calcium) (tablets) Label ), ALTACE (RAMIPRIL) (TABLETS) (View Altace (ramipril) (tablets) Side Effects and Altace (ramipril) (tablets) Label ), ATENOLOL (View Atenolol Side Effects and Atenolol Label ), EFFEXOR (View Effexor Side Effects and Effexor Label ), TYLENOL PM (DIPHENHYDRAMINE, PARACETAMOL) (TABLETS) (View Tylenol Pm (diphenhydramine, Paracetamol) (tablets) Side Effects and Tylenol Pm (diphenhydramine, Paracetamol) (tablets) Label ), ASA (ACETYLSALICYLIC ACID (ACETYLSALICYLIC ACID) (View Asa (acetylsalicylic Acid (acetylsalicylic Acid) Side Effects and Asa (acetylsalicylic Acid (acetylsalicylic Acid) Label ). Patient was hospitalized.

Nipent Side Effects Report: 4872147-7,Febrile Neutropenia, Pain In Extremity, Pneumonia Fungal
on Dec 20, 2005 Male patient from UNITED STATES , 49 years of age, weighting 141.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: febrile neutropenia, pain in extremity, pneumonia fungal. Nipent dosage: 0.1905 Mg/m2 (4 Mg/m2, Q 3 Weeks), Intravenous. During the same period patient was treated with CYCLOPHOSPHAMIDE (28.5714 Mg/m2 (600 Mg/m2, Q 3 Weeks) Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), ACYCLOVIR (View Acyclovir Side Effects and Acyclovir Label ), ALLOPURINOL (View Allopurinol Side Effects and Allopurinol Label ), ZOFRAN (View Zofran Side Effects and Zofran Label ), SEVELAMER HYDROCHLORIDE(SEVELAMER HYDROCHLORIDE) (View Sevelamer Hydrochloride(sevelamer Hydrochloride) Side Effects and Sevelamer Hydrochloride(sevelamer Hydrochloride) Label ), SULFAMETHOXAZOLE/TRIMETHOPRIN (TABLETS) (View Sulfamethoxazole/trimethoprin (tablets) Side Effects and Sulfamethoxazole/trimethoprin (tablets) Label ). Patient was hospitalized.

Nipent Side Effects Report: 4836978-1,Colon Cancer
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: colon cancer on Nov 04, 2005 from UNITED STATES Additional patient health information: Female patient , 44 years of age, was diagnosed with t-cell lymphoma and. Nipent dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Side Effects and Methotrexate Label ), ETANERCEPT (View Etanercept Side Effects and Etanercept Label ), TBI (View Tbi Side Effects and Tbi Label ).

Nipent Side Effects Report: 4823602-7,Dialysis, Metabolic Acidosis, Renal Failure Acute, Respiratory Failure
Adverse event was reported on Oct 20, 2005 by a Female patient taking Nipent (Nipent Label) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 64 years of age, After Nipent was administered, patient had the following side effects: dialysis (What is dialysis?), metabolic acidosis, renal failure acute, respiratory failure. During the same period patient was treated with RITUXAN (View Rituxan Side Effects and Rituxan Label ), CYTOXAN (View Cytoxan Side Effects and Cytoxan Label ), FLUDARA (View Fludara Side Effects and Fludara Label ). Patient was hospitalized.

Nipent Side Effects Report: 4819826-5,Alveolitis, Blood Bilirubin Increased, Bone Marrow Failure, Cholestasis, Dyspnoea, Escherichia Sepsis, Haemodialysis, Multi-organ Failure, Renal Failure Acute
on Oct 21, 2005 Male patient from GERMANY , 57 years of age, weighting 189.6 lb, was diagnosed with graft versus host disease and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: alveolitis, blood bilirubin increased, bone marrow failure, cholestasis, dyspnoea, escherichia sepsis, haemodialysis, multi-organ failure, renal failure acute. Nipent dosage: (0.5 Mg), Intravenous. During the same period patient was treated with ACYCLOVIR (View Acyclovir Side Effects and Acyclovir Label ), DECORTIN (View Decortin Side Effects and Decortin Label ), KALINOR (View Kalinor Side Effects and Kalinor Label ), NEXIUM (View Nexium Side Effects and Nexium Label ), NITRO (View Nitro Side Effects and Nitro Label ), NORVASC (View Norvasc Side Effects and Norvasc Label ), AUGMENT (View Augment Side Effects and Augment Label ), PANTOZOL (View Pantozol Side Effects and Pantozol Label ).

Nipent Side Effects Report: 4819645-X,Abdominal Pain, Blood Pressure Decreased, Chills, Dehydration, Diarrhoea, Heart Rate Increased, Pyrexia, Renal Failure, Sepsis
on Oct 25, 2005 Male patient from UNITED STATES , 64 years of age, weighting 199.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood pressure decreased, chills, dehydration, diarrhoea, heart rate increased, pyrexia, renal failure, sepsis (What is sepsis?). Nipent dosage: 0.0952 Mg (2 Mg, Q21), Intravenous. During the same period patient was treated with RITUXIMAB (17.8571 Mg (375 Mg, Q21) Intravenous) (View Rituximab Side Effects and Rituximab Label ), CYCLOPHOSPHAMIDE (28.5714 Mg (600 Mg, Q21d), Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), COZAAR (View Cozaar Side Effects and Cozaar Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Side Effects and Rabeprazole Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Side Effects and Calcium Carbonate Label ), ERGOCALCIFEROL (View Ergocalciferol Side Effects and Ergocalciferol Label ), VERAPAMIL (View Verapamil Side Effects and Verapamil Label ), URSODIOL (View Ursodiol Side Effects and Ursodiol Label ). Patient was hospitalized.

Nipent Side Effects Report: 4816785-6,Cystitis, Laryngitis, Mucosal Inflammation
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: cystitis, laryngitis, mucosal inflammation on Oct 19, 2005 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 4 Mg/m2 Intravenous. During the same period patient was treated with CYCLOPHOSPHAMIDE (600 Mg/m2, Intravenous) (View Cyclophosphamide Side Effects and Cyclophosphamide Label ), RITUXIMAB (375 Mg/m2, Intravenous) (View Rituximab Side Effects and Rituximab Label ), DECADRON (View Decadron Side Effects and Decadron Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Side Effects and Tylenol (caplet) Label ), BENADRYL (View Benadryl Side Effects and Benadryl Label ), PROTONIX (View Protonix Side Effects and Protonix Label ), ACYCLOVIR (View Acyclovir Side Effects and Acyclovir Label ), BACTRIM (View Bactrim Side Effects and Bactrim Label ). Patient was hospitalized.

Nipent Side Effects Report: 4816619-X,Atrial Fibrillation, Back Pain, Benign Prostatic Hyperplasia, Citrobacter Infection, Dehydration, Dilatation Atrial, Oedema Peripheral, Pain In Extremity, Pneumonia
Adverse event was reported on Oct 13, 2005 by a Male patient taking Nipent (Nipent Label) (Dosage: 0.1905 Mg/m2 (4 Mg/m2,q21d), Intravenous) was diagnosed with b-cell small lymphocytic lymphoma, chronic lymphocytic leukaemia and. Location: UNITED STATES , 79 years of age, weighting 154.6 lb, After Nipent was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), benign prostatic hyperplasia, citrobacter infection, dehydration, dilatation atrial, oedema peripheral, pain in extremity, pneumonia (What is pneumonia?). During the same period patient was treated with RITUXAN (17.8571 Mg/m2 (375 Mg/m2,q21d), Intravenous) (View Rituxan Side Effects and Rituxan Label ), NORVASC (View Norvasc Side Effects and Norvasc Label ), ASPIRIN (View Aspirin Side Effects and Aspirin Label ), PROSCAR (View Proscar Side Effects and Proscar Label ), VITORIN (View Vitorin Side Effects and Vitorin Label ), LISINOPRIL (View Lisinopril Side Effects and Lisinopril Label ), TOPROL (TOPROL XL) (View Toprol (toprol Xl) Side Effects and Toprol (toprol Xl) Label ). Patient was hospitalized.

Nipent Side Effects Report: 4784558-9,Complications Of Transplant Surgery, Delayed Engraftment, Neutrophil Count Decreased, White Blood Cell Count Decreased
on Sep 16, 2005 Female patient from UNITED STATES , 33 years of age, weighting 139.1 lb, was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: complications of transplant surgery, delayed engraftment, neutrophil count decreased, white blood cell count decreased. Nipent dosage: . Patient was hospitalized.

Nipent Side Effects Report: 4777583-5,Acidosis, Gastroenteritis, Renal Failure
on Sep 16, 2005 Female patient from UNITED STATES , 72 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: acidosis, gastroenteritis (What is gastroenteritis?), renal failure. Nipent dosage: 0.1905 Mg/m2 (2 Mg/m2, Every 21 Days), Intravenous. During the same period patient was treated with RITUXAN (17.8571 Mg/m2 (275 Mg/m2, Every 21 Days), Intravenous) (View Rituxan Side Effects and Rituxan Label ), CYTOXAN (28.5714 Mg/m2 (600 Mg/m2, Every 21 Days), Intravenous) (View Cytoxan Side Effects and Cytoxan Label ). Patient was hospitalized.

Nipent Side Effects Report: 4777451-9,Dehydration, Fluid Intake Reduced, Malaise, Pyrexia, Tumour Lysis Syndrome
Patient was taking Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome on Sep 09, 2005 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: (7.6 Mg), Intravenous. During the same period patient was treated with CYTOXAN ((1140 Mg), Intravenous) (View Cytoxan Side Effects and Cytoxan Label ), RITUXAN ((712.5 Mg), Intravenous) (View Rituxan Side Effects and Rituxan Label ), ALEVE (View Aleve Side Effects and Aleve Label ), ASPIRIN (View Aspirin Side Effects and Aspirin Label ), FLOMAX (View Flomax Side Effects and Flomax Label ), PROCARDIA (View Procardia Side Effects and Procardia Label ), LOZOL (View Lozol Side Effects and Lozol Label ), ALLOPURINOL (View Allopurinol Side Effects and Allopurinol Label ). Patient was hospitalized.

Nipent Side Effects Report: 4745526-6,Cystitis Haemorrhagic, Haematuria
Adverse event was reported on Apr 19, 2002 by a Male patient taking Nipent (Nipent Label) (Dosage: -- (0.5 Mg/m2), Intravenous) was diagnosed with prophylaxis against transplant rejection and. Location: UNITED STATES , 22 years of age, After Nipent was administered, patient had the following side effects: cystitis haemorrhagic, haematuria. During the same period patient was treated with TACROLIMUS (View Tacrolimus Side Effects and Tacrolimus Label ), INFLIXIMAB (View Infliximab Side Effects and Infliximab Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Side Effects and Immune Globulin Intravenous (human) Label ), ZENAPAX (View Zenapax Side Effects and Zenapax Label ), AMPHOTERICIN B (View Amphotericin B Side Effects and Amphotericin B Label ), AMBISOME (View Ambisome Side Effects and Ambisome Label ), TEQUIN (View Tequin Side Effects and Tequin Label ), PHOTOPHERESIS (View Photopheresis Side Effects and Photopheresis Label ). Patient was hospitalized.

Nipent Side Effects Report: 4734615-8,Chills, Hypotension, Nausea, Oliguria, Pyrexia, Sepsis, Septic Shock
on Jul 22, 2005 Female patient from UNITED STATES , 69 years of age, weighting 155.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (Nipent Label). After Nipent was administered, patient had the following side effects: chills, hypotension, nausea (What is nausea?), oliguria, pyrexia, sepsis (What is sepsis?), septic shock. Nipent dosage: 0.3333 Mg (7 Mg, Q3weeks), Intravenous. During the same period patient was treated with RITUXAN (31.4286 Mg (660 Mg, Q3weeks), Intravenous) (View Rituxan Side Effects and Rituxan Label ), CYTOXAN (50.2857 Mg (1056 Mg, Q3weeks),intravenous) (View Cytoxan Side Effects and Cytoxan Label ), SYNTHROID (View Synthroid Side Effects and Synthroid Label ), ATENOLOL (View Atenolol Side Effects and Atenolol Label ), DIOVAN (View Diovan Side Effects and Diovan Label ), LIPITOR (View Lipitor Side Effects and Lipitor Label ), PHENERGAN (View Phenergan Side Effects and Phenergan Label ), ALLOPURINOL (View Allopurinol Side Effects and Allopurinol Label ). Patient was hospitalized.

< Previous Nipent Side Effects Page  Showing 81-120 of 95 Next Nipent Side Effects Page>


Share Your Experience, Join the Discussion:

Go to the top of the page

Nipent User Reviews -

Nipent Side Effects Questions and Comments

No comments have been provided.

Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.<<<<

nipent Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: prograf Episodes: 2: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 7: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: nitric Episodes: 2: Diagnosed with major depression.Side ...<<<<

© 2006-2010 Artek LLC | Design by styleshout | Home | Privacy | Terms | About | Contact us PatientsVille.com does not provide medical ...<<<<

nipent Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: novantrone Episodes: 1: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: norvasc Episodes: 1: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: nutropin Episodes: 2: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: nitisinone Episodes: 2: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: nizoral Episodes: 1: Diagnosed with major depression.Side ...<<<<

nipent Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: norco Episodes: 2: Diagnosed with major depression.Side ...<<<<

> Medical Devices

> Side Effects Wiki

Follow Nipent Side Effects on Twitter

Nipent Side Effects
Nipent and Abdominal PainWhat is Abdominal pain?
Nipent and Acute Respiratory Distress Syndrome
Nipent and Anaemia
Nipent and Asthenia
Nipent and Atrial FibrillationWhat is Atrial fibrillation?
Nipent and Balance Disorder
Nipent and Basal Cell Carcinoma
Nipent and Blood Glucose Increased
Nipent and Bradycardia
Nipent and Bronchopulmonary Aspergillosis
Nipent and Cardiac Failure Congestive
Nipent and Cardiomegaly
Nipent and Chest PainWhat is Chest pain?
Nipent and Chills
Nipent and Colon Cancer
Nipent and Cough
Nipent and Dehydration
Nipent and Diarrhoea
Nipent and Dyspnoea
Nipent and Hypotension
Nipent and Metabolic Acidosis
Nipent and NauseaWhat is Nausea?
Nipent and PneumoniaWhat is Pneumonia?
Nipent and Pulmonary Oedema
Nipent and Pyrexia
Nipent and Renal Failure
Nipent and Renal Failure Acute
Nipent and SepsisWhat is Sepsis?
Nipent and Tumour Lysis Syndrome
Nipent and Vomiting
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com and viewing information about Nipent Side Effects: NIPENT and multiple myeloma,NIPENT and adult t-cell lymphoma/leukaemia,NIPENT and diffuse large b-cell lymphoma,NIPENT and mantle cell lymphoma,NIPENT and breast cancer,NIPENT and oesophageal carcinoma,NIPENT and prostate cancer,NIPENT and colon cancer,NIPENT and metastasis,NIPENT and lung neoplasm malignant,NIPENT and squamous cell carcinoma,NIPENT and basal cell carcinoma,NIPENT and skin cancer,NIPENT and disease recurrence,NIPENT and pericarditis,NIPENT and alanine aminotransferase increased,NIPENT and aspartate aminotransferase increased,NIPENT and blood lactate dehydrogenase increased,NIPENT and hyperbilirubinaemia,NIPENT and hyperkalaemia,NIPENT and hyperphosphataemia,NIPENT and hyponatraemia,NIPENT and metabolic acidosis,NIPENT and renal failure,NIPENT and anxiety,NIPENT and asthenia,NIPENT and dementia alzheimer's type,NIPENT and depression,NIPENT and muscle spasms,NIPENT and anaemia,NIPENT and enteritis,NIPENT and herpes zoster,NIPENT and leukopenia,NIPENT and lymphadenopathy,NIPENT and neutropenia,NIPENT and upper respiratory tract infection,NIPENT and acute respiratory distress syndrome,NIPENT and cardiomegaly,NIPENT and hepatosplenomegaly,NIPENT and lung consolidation,NIPENT and pulmonary fibrosis,NIPENT and sepsis,NIPENT and urinary bladder haemorrhage,NIPENT and aplasia pure red cell,NIPENT and palpitations,NIPENT and respiratory failure,NIPENT and sepsis syndrome,NIPENT and hypocalcaemia,NIPENT and hypokalaemia,NIPENT and pyrexia,NIPENT and urinary tract infection,NIPENT and body temperature increased,NIPENT and cardiac failure congestive,NIPENT and hypotension,NIPENT and multi-organ failure,NIPENT and oedema,NIPENT and pneumonia,NIPENT and pneumonitis,NIPENT and blood potassium decreased,NIPENT and atrial fibrillation,NIPENT and pulmonary oedema,NIPENT and febrile neutropenia,NIPENT and pain in extremity,NIPENT and pneumonia fungal,NIPENT and dialysis,NIPENT and renal failure acute,NIPENT and alveolitis,NIPENT and blood bilirubin increased,NIPENT and bone marrow failure,NIPENT and cholestasis,NIPENT and dyspnoea,NIPENT and escherichia sepsis,NIPENT and haemodialysis,NIPENT and abdominal pain,NIPENT and blood pressure decreased,NIPENT and chills,NIPENT and dehydration,NIPENT and diarrhoea,NIPENT and heart rate increased,NIPENT and cystitis,NIPENT and laryngitis,NIPENT and mucosal inflammation,NIPENT and back pain,NIPENT and benign prostatic hyperplasia,NIPENT and citrobacter infection,NIPENT and dilatation atrial,NIPENT and oedema peripheral,NIPENT and complications of transplant surgery,NIPENT and delayed engraftment,NIPENT and neutrophil count decreased,NIPENT and white blood cell count decreased,NIPENT and gastroenteritis,NIPENT and fluid intake reduced,NIPENT and malaise,NIPENT and tumour lysis syndrome,NIPENT and cystitis haemorrhagic,NIPENT and haematuria,NIPENT and nausea,NIPENT and oliguria,NIPENT and septic shock